China HK Power won the 20-year franchise operation right of the concentrated energy station project in Songshan Lake Science and Technology Intelligent Housing in Dongguan city.

China HK Power (00931) announced that the company has successfully won the 20-year concession operation rights for the centralized energy station project in Songshan Lake Science and Technology Innovation City, Dongguan City on July 11, 2024. The company will invest in building a centralized energy station to provide comprehensive energy services for park enterprises, including refrigeration, heating, steam, compressed gas supply, energy storage, charging stations, photovoltaic power generation, etc. The 30-day countdown for signing a formal contract starts from the date of bid notification. Songshan Lake Science and Technology Innovation City is built with an investment of 4.5 billion yuan by Dongguan Songshan Lake High-tech Industrial Development Zone Management Committee, a wholly-owned subsidiary of Dongguan Songshan Lake Science City Development Group Co., Ltd.

新浪港股Jul 11 19:19 ET

Asymchem Laboratories expects its first-half revenue to be around 2.66 billion to 2.74 billion yuan, a year-on-year decrease of 40.72% to 42.45%.

Asymchem Laboratories (06821) announced that the group expects the net income attributable to shareholders of the company for the reporting period from January 1, 2024 to June 30, 2024 to be approximately RMB 0.48 billion to 0.55 billion, a year-on-year decrease of about 67.39% to 71.54%. In the first half of 2024, the company achieved revenue of approximately RMB 2.66 billion to 2.74 billion, a year-on-year decrease of 40.72% to 42.45%, mainly due to the delivery of substantial orders in the same period last year, and no relevant orders this year. During the reporting period, the company faced a sustained downturn in the biomedical financing environment both domestically and overseas.

新浪港股Jul 10 19:25 ET

Hesen Biotech acquires 14 branded pharmaceuticals from Celltrion, enriching product pipeline in 8 countries.

On June 28th, Heisen Biotech Co., Ltd. (Heisen Biotech) announced that it has officially completed the acquisition of the commercial rights of 14 branded products under the South Korean biopharmaceutical company Celltrion in multiple countries and regions in the Asia-Pacific region, and holds the marketing authorization holder (MAH) rights for these products in eight countries and regions including South Korea (excluding Nexinavir, Yidabio and Aiketuo), Singapore, Thailand, Australia, and Hong Kong, China. It is reported that this acquisition will enrich the company's product pipeline in eight countries and regions outside of mainland China and establish a more complete international supply chain and quality system.

新浪科技Jun 28 05:11 ET

Why is Fosun Pharma privatizing Henlius at this time? | Jianzhi Research

The suspension of Henlius stocks has finally been resolved, consistent with previous market rumors: Fosun Pharma will privatize Henlius for delisting, with a privatization valuation of approximately RMB 12.4 billion. Fosun Pharma's bid for each share of Henlius is HKD 24.60, a premium of 30.6% over its pre-suspension closing price. Based on last year's net profit of CNY 546 million for Henlius, this privatization has a PE ratio of approximately 23 times. The total transaction is HKD 5.4 billion, which will use no more than HKD 3.7 billion in acquisition loans. Henlius has a total share capital of 543.5 million shares, including 163.4 million H shares and 380.1 million non-listed shares. The tenderer in this case is Fosun.

wallstreetcnJun 25 03:26 ET

Huawei Cloud's national storage and computing network hub node layout is fully completed with the opening of the Wuhu datacenter.

On the afternoon of June 14th, Sina Technology reported that Huawei Cloud's East China (Wuhu) datacenter was officially launched, marking the completion of Huawei Cloud's national storage and computing network hub node layout. It also means that the hub node of the cni yangtze index with both numerical processing and algorithmic computing capabilities can provide super-large-scale computing services to the East China and central regions, which will effectively promote the development of AI industry in the relevant regions. Xu Zhijun, Huawei's vice chairman and rotating chairman, said that the Huawei Cloud's East China (Wuhu) datacenter is an important part of the Huawei Cloud map, which can help enterprises use cloud computing power on demand with up-to-date technology while avoiding the need to build their own data centers.

新浪科技Jun 14 03:39 ET

Report: Fosun Pharmaceuticals Considers Privatizing Hong Kong Stock Holding Subsidiary Fu Hong Han Lin

On Monday, according to media reports quoting people familiar with the matter, Fosun Pharmaceutical is considering a privatization acquisition of Fuhong Hanlin, which is listed on the Hong Kong stock market. People familiar with the matter said that Fosun Pharmaceuticals is cooperating with a consulting agency on a potential privatization offer plan, and other investors may also join the deal. Fuhong Hanlin is a holding subsidiary of Fosun Pharmaceutical. Fosun Pharmaceutical holds 53.61% of Fuhong Hanlin's total share capital. Since May 23, Fu Hong Hanlin has suspended trading on the Hong Kong Stock Exchange pending the announcement of the merger and acquisition. Negotiations are still ongoing, and it remains to be seen whether a deal will actually be reached in the future.

wallstreetcnMay 29 09:12 ET